Severe Sepsis

3

Review clinical trials related to Severe Sepsis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

1\. To research the current situation of severe infection in children in China, and to investigate the incidence, prognosis and disease burden of severe infection in children in different regions of China. 2. Establish the risk prediction model and diagnosi model of severe infection in children, and verify the accuracy of the model in multi-center; 3. To study the effectiveness and safety of different treatments in real diagnosis and treatment, and to evaluate the efficacy of subgroups under different ages and high risk factors.

Participants needed: 5,000
Trial details
Age: 29-18Biological sex: AllType: ObservationalSponsor: Children's Hospital of Fudan UniversityUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Children between 0 and 18 years old. [+1]

notifiable infectious diseases. [+2]

Status: Not yet recruiting

Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis

This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requiring mechanical ventilation and the possibility to predict multi-organ failure. The measurement of alveolar dead space used to require sophisticated equipment and time. New ventilators have microprocessors that allow rapid mathematical calculation with minimal intervention.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: The University of Texas Health Science Center, HoustonUpdated: Jun 11, 2025Locations: 1
Eligibility criteria

Adults with severe sepsis or septic shock on mechanical ventilation [+1]

Patients with withdrawal or hospice order. [+3]

Status: Recruiting

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

Subjects previously enrolled / randomized in the ReActIF-ICE (Recovery from acute immune failure in septic shock by immune cell extracorporeal terapy - immune competence enhancement) study received either standard sepsis treatment (control group) or standard sepsis treatment and additionally the ARTICE treatment (treatment group) during their index hospitalization. All subjects are followed up for 90 days after enrollment. In this long term follow up study, the enrolled subjects shall be followed up beyond 90 days for up to 5 years.

Participants needed: 142
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Artcline GmbHUpdated: Aug 2, 2024Locations: 2
Eligibility criteria

Subject or legal surrogate is willing and able to provide written informed conse... [+1]

none